On-demand PrEP is contraindicated in people with chronic hepatitis B infection

PRINT AS PDF

Of note, the Panel will continue to monitor the data on the efficacy of on-demand PrEP for MSM who use on-demand PrEP less frequently than fortnightly (14, 21).


The Therapeutic Goods Administration (TGA) has not approved this regimen in Australia.